ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Biodesix Inc

Biodesix Inc (BDSX)

1.57
0.21
(15.44%)
Cerrado 21 Diciembre 3:00PM
1.56
-0.01
(-0.64%)
Fuera de horario: 6:54PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
1.56
Postura de Compra
1.38
Postura de Venta
1.60
Volume Operado de la Acción
752,510
1.3201 Rango del Día 1.61
1.11 Rango de 52 semanas 2.21
Capitalización de Mercado [m]
Precio Anterior
1.36
Precio de Apertura
1.35
Última hora de negociación
Volumen financiero
US$ 1,071,942
Precio Promedio Ponderado
1.4245
Volumen promedio (3 m)
417,101
Acciones en circulación
145,467,295
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-4.35
Beneficio por acción (BPA)
-0.36
turnover
49.09M
Beneficio neto
-52.15M

Acerca de Biodesix Inc

Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Mostrar más

Sector
Medical Laboratories
Industria
Medical Laboratories
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Biodesix Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker BDSX. The last closing price for Biodesix was US$1.36. Over the last year, Biodesix shares have traded in a share price range of US$ 1.11 to US$ 2.21.

Biodesix currently has 145,467,295 shares in issue. The market capitalisation of Biodesix is US$197.84 million. Biodesix has a price to earnings ratio (PE ratio) of -4.35.

BDSX Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.2720.93023255811.291.561.282039471.35714107CS
40.3225.80645161291.241.561.2153282511.34180924CS
12-0.14-8.235294117651.71.81.114171011.34478574CS
26-0.06-3.70370370371.622.041.112842631.44812551CS
52-0.06-3.70370370371.622.211.112119121.49380772CS
156-3.28-67.76859504134.845.99730.9551953021.81537927CS
260-12.03-88.520971302413.5931.990.9551766924.29005731CS

BDSX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Biodesix?
El precio actual de las acciones de Biodesix es US$ 1.56
¿Cuántas acciones de Biodesix están en circulación?
Biodesix tiene 145,467,295 acciones en circulación
¿Cuál es la capitalización de mercado de Biodesix?
La capitalización de mercado de Biodesix es USD 197.84M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Biodesix?
Biodesix ha negociado en un rango de US$ 1.11 a US$ 2.21 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Biodesix?
El ratio precio/beneficio de Biodesix es -4.35
¿Cuál es el ratio de efectivo a ventas de Biodesix?
El ratio de efectivo a ventas de Biodesix es 4.62
¿Cuál es la moneda de reporte de Biodesix?
Biodesix presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Biodesix?
El último ingresos anual de Biodesix es USD 49.09M
¿Cuál es el último beneficio anual de Biodesix?
El último beneficio anual de Biodesix es USD -52.15M
¿Cuál es la dirección registrada de Biodesix?
La dirección registrada de Biodesix es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Biodesix?
La dirección del sitio web de Biodesix es www.biodesix.com
¿En qué sector industrial opera Biodesix?
Biodesix opera en el sector MEDICAL LABORATORIES

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

BDSX Discussion

Ver más
PonkenPlonken PonkenPlonken 2 semanas hace
Mr Schuler is buying shares again
👍️0
tw0122 tw0122 2 meses hace
Is selling $250 million in stock fro time to time on the downside.. Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.
👍️0
tw0122 tw0122 2 meses hace
Lung diagnostics cancer revenues improving still has $33m cash $1.49 +'14%
👍️0
AJ Freely AJ Freely 1 año hace
$BDSX - Up 12%/ Current Price $1.34.
Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
👍️0
1hot toddy 1hot toddy 2 años hace
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$
👍️0
Leg58 Leg58 2 años hace
Lots if potential but will public offering dilute price?
👍️0
Leg58 Leg58 2 años hace
Lots if potential but will public offering dilute price?
👍️0
subslover subslover 2 años hace
Earnings look good.
👍️0
subslover subslover 2 años hace
Earnings look good.
👍️0
MiamiGent MiamiGent 2 años hace
BDSX Has news this morning!

The contract covers the company’s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGS™ testing.

https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

https://stockcharts.com/h-sc/ui?s=BDSX
👍️0
carusso carusso 2 años hace
Not so much...
👍️0
crudeoil24 crudeoil24 2 años hace
LET'S GO BDSX !!!!!
👍️0
crudeoil24 crudeoil24 2 años hace
Biodesix to Participate in Two Upcoming Investor Conferences in September
6:00 am ET September 6, 2022 (BusinessWire) Print
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY
👍️0
crudeoil24 crudeoil24 2 años hace
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
👍️0
Leg58 Leg58 2 años hace
US based company is quietly trending up. IMHO.
GLTA
👍️0

Su Consulta Reciente

Delayed Upgrade Clock